|
Perez-Anton E, Egui A, Thomas MC, Carrilero B, Simon M, Lopez-Ruz MA, Segovia M, Lopez MC. A proportion of CD4+ T cells from patients with chronic Chagas disease undergo a dysfunctional process, which is partially reversed by benznidazole treatment. PLoS Negl Trop Dis. 2021 Feb 4;15(2):e0009059. doi: 10.1371/journal.pntd.0009059. eCollection 2021 Feb. PubMed PMID: 33539379; PubMed Central PMCID: PMC7888659.
AÑO: 2021; IF: 4.781
|
33539379
|
Egui A, Thomas MC, Fernandez-Villegas A, Perez-Anton E, Gomez I, Carrilero B, Del Pozo A, Ceballos M, Andres-Leon E, Lopez-Ruz MA, Gainza E, Oquinena E, Segovia M, Lopez MC. A Parasite Biomarker Set for Evaluating Benznidazole Treatment Efficacy in Patients with Chronic Asymptomatic Trypanosoma cruzi Infection. Antimicrob Agents Chemother. 2019 Sep 23;63(10):e02436-18. doi: 10.1128/AAC.02436-18. Print 2019 Oct. PubMed PMID: 31358581; PubMed Central PMCID: PMC6761566.
AÑO: 2019; IF: 4.904
|
|
Gil-Gallardo L, Simon M, Iborra A, Carrilero B, Segovia M. Chemiluminescent Microparticle Immunoassay for the Diagnosis of Congenital Chagas Disease: A Prospective Study in Spain. Am J Trop Med Hyg. 2021 Oct 4;105(6):1701-1705. doi: 10.4269/ajtmh.21-0332. PubMed PMID: 34607304; PubMed Central PMCID: PMC8641311.
AÑO: 2021; IF: 3.707
|
|
Gomez I, Thomas MC, Palacios G, Egui A, Carrilero B, Simon M, Valladares B, Segovia M, Carmelo E, Lopez MC. Differential Expression of Immune Response Genes in Asymptomatic Chronic Chagas Disease Patients Versus Healthy Subjects. Front Cell Infect Microbiol. 2021 Sep 6;11:722984. doi: 10.3389/fcimb.2021.722984. eCollection 2021. PubMed PMID: 34552885; PubMed Central PMCID: PMC8450343.
AÑO: 2021; IF: 6.073
|
|
Vazquez C, Garcia-Vazquez E, Carrilero B, Simon M, Franco F, Iborra MA, Gil-Gallardo LJ, Segovia M. Tolerance and Adherence of Patients with Chronic Chagas Disease Treated with Benznidazole. Rev Soc Bras Med Trop. 2023 Jan 23;56:e0384-2022. doi: 10.1590/0037-8682-0384-2022. eCollection 2023. PubMed PMID: 36700605; PubMed Central PMCID: PMC9870279.
AÑO: 2023; IF: 1.8
|